Skip to main content Accessibility help
×
Home

Role of serotonin in obsessive-compulsive disorder

  • H. G. Baumgarten (a1) (a2) and Z. Grozdanovic (a1)

Abstract

Background Serotonin may play a role in the pathophysiology of obsessive-compulsive disorder (OCD) because of the anti-obsessional effect of selective serotonin reuptake inhibitors (SSRJs).

Method The literature is reviewed on knowledge of the role of serotonergic neurons in brain function, studies on monoamine metabolites in cerebrospinal fluid (CSF), various stress neuropeptides, neuroendocrine and behavioural challenge after administration of direct and indirect serotomimetic compounds, and neuroanatomical data on brain circuits organising behaviour.

Results In most of the OCD cases analysed, CSF 5-hydroxyindoleacetic acid and homovanillic acid concentrations do not significantly differ from age-corrected controls. However, a relationship appears to exist between pre-treatment levels of these metabolites and clinical response to drugs acting on the serotonin transporter. Abnormalities in CSF arginine vasopressin, corticotropin-releasing hormone, oxytocin and somatostatin levels have been reported in OCD. Long-term treatment with high-doses of clomipramine, fluvoxamine, and fluoxetine tend to correct these neuropeptide abnormalities.

Conclusions We hypothesise that continuous treatment with SSRJs alters serotonin turnover and neuropeptide expression patterns in OCD-entertaining functional forebrain/midbrain circuits.

Copyright

Corresponding author

Correspondence: Professor H. G. Baumgarten, Institute of Anatomy, University Clinic Benjamin Franklin, Free University of Berlin, Königin-Luise-Strasse 15, D-14195 Berlin, Germany. Fax: +49 30 838 8445 1902

References

Hide All
Aghahanian, G. K. & Andrade, R. (1997) Electrophysiology of 5-HTreceptors. In Handbook of Experimental Pharmacology. Vol. 129: Serotoninergic Neurons and 5-HT Receptors in the CNS (eds Baumgarten, H. G. & Göthert, M.), pp. 499536. Berlin: Springer-Verlag.
Agren, H., Mefford, I. N., Rudorfer, M. V., et al (1986) Interacting neurotransmitter systems. A non-experimental approach to the 5-HIAA/HVA correlation in human CSF. Journal of Psychiatry Research, 20, 175193.
Altemus, M., Pigott, T., L'Heureux, F., et al (1992) Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive–compulsive disorder. Archives of General Psychiatry, 49, 920.
Altemus, M., Pigott, T., Kalogeras, K. T., et al (1993) CSF somatostatin in obsessive–compulsive disorder. American Journal of Psychiatry, 150, 460464.
Altemus, M., Swedo, S. E., Leonard, H. L., et al (1994) Changes in cerebrospinal fluid neurochemistry during treatment of obsessive–compulsive disorder with clomipramine. Archives of General Psychiatry, 51, 794803.
Asberg, M., Ringberger, V.-A., Sjöquist, F., et al (1977) Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine. Clinical Pharmacology and Therapeutics, 21, 201207.
Barr, L. C., Goodman, W. K. & Price, L. H. (1993) The serotonin hypothesis of obsessive compulsive disorder. International Clinical Psychopharmacology, 8, (suppl. 2), 7982.
Barr, L. C., Goodman, W. K., McDougle, C. J., et al (1994) Tryptophan depletion in patients with obsessive–compulsive disorder who respond to serotonin reuptake inhibitors. Archives of General Psychiatry, 51, 309317.
Bastani, B., Nash, J. F., Meltzer, H.Y. (1990) Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive–compulsive disorder. Archives of General Psychiatry, 47, 833839.
Baumgarten, H. G. & Grozdanovic, Z. (1994) Neuroanatomy and neurophysiology of central serotonergic systems. Journal of Serotonin Research, 1, 171179.
Baumgarten, H. G. & Grozdanovic, Z. (1995) Psychopharmacology of central serotonergic systems. Pharmacopsychiatry, 28 (suppl. 11), 7379.
Baumgarten, H. G. & Grozdanovic, Z. (1997) Anatomy of central serotoninergic projection systems. In Handbook of Experimental Pharmacology, Vol. 129: Serotoninergic Neurons and 5-HT Receptors in the CNS (eds Baumgarten, H. G. & Göthert, M.), pp. 4189. Berlin: Springer-Verlag.
Z., Berg, C., Whitaker, A., Davies, M., et al (1988) The survey form of the Leyton Obsessional Inventory – Child Version. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 759763.
Bertilsson, L., Tuck, J. R. & Siwers, B. (1980) Biochemical effects of zimelidine in man. European journal of Clinical Pharmacology, 18, 483487.
Bjerkenstedt, L., Edman, G., Flyckt, L., et al (1985) Clinical and biochemical effects of citalopram, a selective 5-HTreuptake inhibitor – a dose-response study in depressed patients. Psychopharmacology, 87, 253259.
D., Brewerton, T. (1995) Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology, 20, 561590.
Brown, S. L. & van Praag, H. M. (eds) (1991) The role of serotonin in psychiatric disorders. Clinical and Experimental Psychiatry Monographs, No 4. New York: Brunner-Mazel Publishers.
Broderick, P. A. & Phelix, C. F. (1997) 1. Serotonin (5-HT) within dopamine reward circuits signals open-field behaviour. Neuroscience and Behavioural Reviews, 21, 227260.
Castanon, N., Ramboz, S., Saudou, F., et al (1997) Behavioral consequences of 5-HTIB receptor gene selection. In Handbook of Experimental Pharmacology, Vol. 129: Serotoninergic Neurons and 5-HT Receptors in the CNS (eds Baumgarten, H.G. & Göthert, M.), pp. 351366. Berlin: Springer-Verlag.
Charney, D. S., Goddman, W. K., Price, L. H., et al (1988) Serotonin function in obsessive–compulsive disorder: a comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Archives of General Psychiatry, 45, 177185.
Dewey, S. L., Smith, G. S., Logan, J., et al (1995) Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. Journal of Neuroscience, 15, 821829.
Dolberg, O. T., Sasson, Y., Cohen, R., et al (1995) The relevance of behavioural probes in obsessive–compulsive disorder. European Neuropsychopharmacoiogy, 5, 161162.
Fatemi, S. H., Meltzer, H. Y. & Roth, B. L. (1996) Interaction of atypical antipsychotic drugs with non-dopaminergic systems. In Handbook of Experimental Pharmacology Vol. 120: Antipsychotics (ed. Csernansky, J. G.), pp. 77115. Berlin: Springer-Verlag.
Fineberg, N. A., Cowen, P. j., Kirk, J. W., et al (1994) Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder. Journal of Affective Disorders, 32, 97104.
Goodman, W. K. (1992) Pharmacotherapy of obsessive–compulsive disorder. In Zwangsstörungen. Duphar Medical Communication, Band 5 (eds Hand, I., Goodman, W. K. & Evers, U.), pp. 141151. Berlin: Springer-Verlag.
Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989a) The Yale–Brown Obsessive–Compulsive Scale (Y–BOCS): Part I. Development, use and reliability. Archives of General Psychiatry, 46, 10061011.
Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989b) Efficacy of fluvoxamine in obsessive–compulsive disorder. A double-blind comparison with placebo. Archives of General Psychiatry, 46, 3643.
Greist, J. H., Jefferson, J.W., Kobak, K. A., et al (1995) Efficacy and tolerability of serotonin transport inhibitors in obsessive–compulsive disorder. Archives of General Psychiatry, 52, 5360.
Greist, J. H. & Jefferson, J.W., (1998) Pharmacotherapy for obsessive compulsive disorder. British Journal Psychiatry, 173 (suppl. 35), 6470.
R., Heninger, G. (1995) Indoleamines. The role of serotonin in clinical disorder. In Psychopharmacology. The Fourth Generation of Progress (eds Bloom, F. E. & Kupfer, D.J.), pp. 471482. New York: Raven Press.
Hewlett, W. A., Vinogradov, S., Berman, S., et al (1992) Fenfluramine stimulation of prolactin in obsessive–compulsive disorder. Psychiatry Research, 42, 8192.
Hollander, E., M., DeCaria, C., Nitescu, A., et al (1992) Serotonergic function in obsessive compulsive disorder: behavioral and neuroendocrine responses to m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Archives of General Psychiatry, 49, 2128.
R., Insel, T. & Pickar, D. (1983) Naloxone administration in obsessive–compulsive disorder: report of two cases. American Journal of Psychiatry, 140, 12191220.
R., Insel, T., Mueller, E. A., Alterman, I., et al (1985) Obsessive–compulsive disorder and serotonin: is there a connection? Biological Psychiatry, 203, 11741188.
Jacobs, B. L. & Fornal, C. A. (1993) 5-HTand motor control: a hypothesis. Trends in Neurosciences, 16, 346352.
Kakigi, T., Maeda, K., Kaneda, H., et al (1992) Repeated administration of antidepressant drugs reduces regional somatostatin concentrations in rat brain. Journal of Affective Disorders, 25, 215220.
Kapur, S. & Remington, G. (1996) Serotonin–dopamine interaction and its relevance to schizophrenia. American Journal of Psychiatry, 153, 466476.
Kruesi, M. J. P., Swedo, S., Leonard, H., et al (1990) CSF somatostatin in childhood psychiatric disorder: a preliminary investigation. Psychiatry Research, 33, 277284.
Leckman, J. F., Goodman, W. K., North, W. G., et al (1994) Elevated levels of CSF oxytocin in obsessive–compulsive disorder. Archives of General Psychiatry, 51, 782791.
Leckman, J. F., Goodman, W. K., Anderson, G. M., et al (1995) Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology, 12, 7386.
Lee, M. A., Cameron, O. G., Gurguis, G. N. M., et al (1990) α2-Adrenoceptor status in obsessive–compulsive disorder. Biological Psychiatry, 27, 10831093.
Leonard, H. L., Swedo, S. E., Rapoport, J. L., et al (1989) Treatment of obsessive–compulsive disorder with clomipramine and desipramine in children and adolescents. Archives of General Psychiatry, 46, 10881092.
Lesch, K. P., Hoh, A., Schulte, H. M., et al (1991a) 5-Hydroxytryptamine IA-receptor responsivity in obsessive compulsive disorder, comparison of patients and controls. Archives of General Psychiatry, 48, 540547
Lesch, K. P., Hoh, A., Schulte, H. M., et al (1991b) Long-term fluoxetine treatment decreases 5-HTIA receptor responsivity in obsessive–compulsive disorder. Psychopharmacology, 105, 415420.
Linnoila, M., Virkkunen, M., George, T., et al (1993) Impulse control disorders. International Clinical Psychopharmacology, 8 (suppl. 1), 5356.
López-Ibor, J. J. Jr (1988) The involvement of serotonin in psychiatric disorders and behaviour. British Journal of Psychiatry, 153 (suppl. 3), 2639.
Lucey, J.V. (1994) Towards a neuroendocrinology of obsessive–compulsive disorder. Journal of Psychopharmacology, 8, 250257.
Lucey, J.V., Butcher, G., Clare, A. W., et al (1992) Busiprione induced prolactin responses in obsessive compulsive disorder. International Clinical Psychopharmacology, 7, 4549.
Lucey, J.V., Butcher, G., Clare, A. W., et al (1994) A pilot study of a neuroendocrine test battery in obsessive compulsive disorder. Journal of Serotonin Research, 1, 7378.
McBride, P. A., DeMeo, M. D., Sweeney, J. A., et al (1992) Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist D, L-fenfluramine in adults with obsessive-compulsive disorder. Biological Psychiatry, 31, 1934.
McDougle, J. C., Goodman, W. K. & Price, L. H. (1994) Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. Journal of Clinical Psychiatry, 55, (suppl. 3), 2431.
Maes, M. & Meltzer, H. Y. (1995) The serotonin hypothesis of major depression. In Psychopharmacology The Fourth Generation of Progress (eds Bloom, F. E. & Kupfer, D.J.), pp. 933944. New York: Raven Press.
Mendlewicz, J. (1992) Efficacy of fluvoxamine in severe depression. Drugs, 43 (suppl. 2), 3239.
Modell, J. G., Mountz, J. M., Curtis, G. C., et al (1989) Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. Journal of Neuropsychiatry, 1, 2736.
Montgomery, S. A. (1996) Long-term management of obsessive-compulsive disorder. International Clinical Psychopharmacology, 11 (suppl. 5), 2329.
Murphy, D. L., Pickar, D. & Atterman, I. S. (1982) Methods for the quantitative assessment of depressive and manic behavior. In Techniques for the Evaluation of the Behavior of Psychiatric Patients (eds Burdock, E. I., Sudilovsky, A. & Gershon, S.), pp. 355392. New York: Marcel Dekker Inc.
Murphy, D. L. & Pigott, T. A. (1990) A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. Journal of Clinical Psychiatry, 51 (suppl. 4), 5360.
Price, L. H., Goddard, A. W., Barr, L. C., et al (1995) Pharmacologic challenges in anxiety disorders. In Psychopharmacology. The Fourth Generation of Progress (eds Bloom, F. E. & Kupfer, D. J.), pp. 13111323. New York: Raven Press.
Rauch, S. L. & Jenike, M. A. (1993) Neurobiological models of obsessive-compulsive disorder. Psychosomatics, 34, 2032.
Salin, P., Mercugliano, M. & Chesselet, M. F. (1990) Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens and frontal cortex of the rat. Cellular and Molecular Neurobiology, 10, 127144.
Smith, C. E., Ware, C. J. & Cowen, P. J. (1991) Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan. Psychopharmacology, 103, 140142.
Sorensen, S. M., Kehne, J. H., Fadayl, E. M., et al (1993) Characterization of the 5-HT2 antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. Journal of Pharmacology and Experimental Therapeutics, 266, 684691.
Soubrié, P. (1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behavioral and Brain Sciences, 9, 319364.
Spoont, M. R. (1992) Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychological Bulletin, 112, 330350.
Stein, D. J., Spadaccini, E. & Hollander, E. (1995) Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. International Clinical Psychopharmacology, 10, 1118.
Sugihara, I., Lang, E. J. & Llinas, R. (1995) Serotonin modulation of inferior olivary oscillations and synchronicity: a multiple-electrode study in the rat cerebellum. European Journal of Neuroscience, 7, 521534.
Swedo, S. E., Leonard, J. L., Kruesi, M. J. P., et al (1992) Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 49, 2936.
Törk, I. (1990) Anatomy of the serotonergic system. Annals of the New York Academy of Sciences, 487, 168174.
Thoren, P., Asberg, M., Cronhol, B., et al (1980a) Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Archives of General Psychiatry, 37, 12811285.
Thoren, P., Asberg, M., Bertilsson, L., et al (1980b) Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. Archives of General Psychiatry, 37, 12891294.
Träskman-Bendz, L., Asberg, M. & Bertilsson, L. (1981) Serotonin and noradrenaline uptake inhibitors in the treatment of depression – relationship to 5-HIAA in spinal fluid. Acta Psychiatrica Scandinavica, 63, (suppl. 290), 209218.
van de Kar, L. D. & Brownfield, M. S. (1993) Serotonergic neurons and neuroendocrine function. Trends in Pharmacological Sciences, 8, 202207.
Zohar, J., Mueller, E. A., Insel, T. R., et al (1987) Serotonergic responsivity in obsessive-compulsive disorder. Archives of General Psychiatry, 44, 946951.

Role of serotonin in obsessive-compulsive disorder

  • H. G. Baumgarten (a1) (a2) and Z. Grozdanovic (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Role of serotonin in obsessive-compulsive disorder

  • H. G. Baumgarten (a1) (a2) and Z. Grozdanovic (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *